01 1Shizuoka Caffeine Industry Co., Ltd.
01 1Sobuzoxane
01 1Japan
Registration Number : 217MF10612
Registrant's Address : 129 Suidocho, Aoi Ward, Shizuoka City, Shizuoka Prefecture
Initial Date of Registration : 2005-09-14
Latest Date of Registration : 2009-03-16
39
PharmaCompass offers a list of Sobuzoxane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sobuzoxane manufacturer or Sobuzoxane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sobuzoxane manufacturer or Sobuzoxane supplier.
PharmaCompass also assists you with knowing the Sobuzoxane API Price utilized in the formulation of products. Sobuzoxane API Price is not always fixed or binding as the Sobuzoxane Price is obtained through a variety of data sources. The Sobuzoxane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sobuzoxane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sobuzoxane, including repackagers and relabelers. The FDA regulates Sobuzoxane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sobuzoxane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sobuzoxane supplier is an individual or a company that provides Sobuzoxane active pharmaceutical ingredient (API) or Sobuzoxane finished formulations upon request. The Sobuzoxane suppliers may include Sobuzoxane API manufacturers, exporters, distributors and traders.
click here to find a list of Sobuzoxane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sobuzoxane Drug Master File in Japan (Sobuzoxane JDMF) empowers Sobuzoxane API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sobuzoxane JDMF during the approval evaluation for pharmaceutical products. At the time of Sobuzoxane JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sobuzoxane suppliers with JDMF on PharmaCompass.
